Showing results (91-100 of 863) with videos related to
Sort By:
Pageof 87
Seminars in Thrombosis and Hemostasis|January 14, 2004
New anticoagulantsLori-Ann Linkins, Jeffrey I WeitzCardiovascular Toxicology|April 2, 2003
Direct thrombin inhibitors in cardiac diseaseJeffrey I Weitz, Eric R BatesExpert Opinion on Investigational Drugs|April 23, 2004
Ximelagatran: the first oral direct thrombin inhibitorMark A Crowther, Jeffrey I WeitzAnnual Review of Medicine|January 22, 2005
New anticoagulant therapyLori-Ann Linkins, Jeffrey I WeitzBritish Journal of Haematology|June 29, 2006
The status of new anticoagulantsShannon M Bates, Jeffrey I WeitzExpert Opinion on Investigational Drugs|February 17, 2007
Beyond heparin and warfarin: the new generation of anticoagulantsJeffrey I Weitz, Lori-Ann LinkinsHamostaseologie|April 16, 2021
Factor XI as a Target for New AnticoagulantsJames C Fredenburgh, Jeffrey I WeitzArteriosclerosis, Thrombosis, and Vascular Biology|August 31, 2023
New Therapeutic Targets for the Prevention and Treatment of Venous Thromboembolism With a Focus on Factor XI InhibitorsNoel C Chan, Jeffrey I WeitzFrontiers in Medicine|March 14, 2017
Factors XI and XII as Targets for New AnticoagulantsJeffrey I Weitz, James C FredenburghJournal of Thrombosis and Thrombolysis|November 3, 2009
Update on heparin: what do we need to know?Daniel S Weitz, Jeffrey I WeitzPageof 87